Latest news
What Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 21:15:24 GMTCLDX SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:14:13 GMTCelldex Therapeutics (NASDAQ: CLDX) ramps barzolvolimab spend, raises $324M - Stock TitanStock Titan · Thu, 06 Aug 2026 20:08:23 GMTWhy Celldex Therapeutics (CLDX) Is Up 7.9% After Phase 2 Prurigo Nodularis Results And What's Next - webull.comwebull.com · Tue, 04 Aug 2026 02:01:56 GMTCelldex Therapeutics (CLDX) After Phase 2 Trial Results As Valuation Questions Come Into Focus - SahmSahm · Fri, 31 Jul 2026 07:00:00 GMTCelldex Therapeutics Inc (CLDX) Balance Sheet - TradingKeyTradingKey · Mon, 27 Jul 2026 06:39:50 GMTCelldex Therapeutics Inc (CLDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Sun, 26 Jul 2026 05:29:00 GMT